PeptiDream Inc. (TYO:4587)

PeptiDream Revenue

PeptiDream had revenue of 4.46B JPY in the quarter ending June 30, 2026, with 3.51% growth. This brings the company's total for the last twelve months to 19.20B, up 0.62% year-over-year. In the year 2025, PeptiDream had annual revenue of 18.52B, down -60.32%. That makes PeptiDream the 21,145th largest company in the world by revenue and 2,292nd in Japan.

• Revenue (ttm): 19.20B
• Revenue Growth: +0.62%
• P/S Ratio: 7.10
• Revenue / Employee: 25.17M
• Employees: 763
• Market Cap: 136.41B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Radioactive Pharmaceutical Business 16.88B 85.8%
• Drug Discovery and Development Business 2.79B 14.2%

By Geography

Chart

• Japan 15.76B 85.1%
• United States of America 1.68B 9.1%
• Europe 763.08M 4.1%
• Other 316.83M 1.7%

Fiscal year ended Dec 31, 2025 See the full PeptiDream breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	18.52B	-28.16B	-60.32%
Dec 31, 2024	46.68B	17.96B	62.57%
Dec 31, 2023	28.71B	1.86B	6.93%
Dec 31, 2022	26.85B	17.49B	186.70%
Dec 31, 2021	9.37B	-2.31B	-19.79%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error